awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q34660907-3F0E3A9B-BE09-411C-9682-95B7761818D5
Q34660907-3F0E3A9B-BE09-411C-9682-95B7761818D5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34660907-3F0E3A9B-BE09-411C-9682-95B7761818D5
PEAK: a randomized, multicenter phase II study of panitumumab plus modified fluorouracil, leucovorin, and oxaliplatin (mFOLFOX6) or bevacizumab plus mFOLFOX6 in patients with previously untreated, unresectable, wild-type KRAS exon 2 metastatic color
P304
Q34660907-3F0E3A9B-BE09-411C-9682-95B7761818D5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34660907-3F0E3A9B-BE09-411C-9682-95B7761818D5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
523c3a14007fb06caf6c03384e52d5010ecf45d9
P304
2240-2247
http://www.w3.org/2001/XMLSchema#string